BIO-Europe 2026
Talk Presenting Companies (Theatre A) track
CNS/Neurology: Avecho Biotechnology
Tue, Nov 10, 2026 · 1:15–1:30 PM CET Koelnmesse
About this session
Avecho Biotechnology Limited (ASX: AVE) is an Australian clinical-stage biopharmaceutical company that develops differentiated pharmaceutical products and advances them through clinical development to commercialisation and licensing. The company builds on a proprietary drug-delivery platform, TPM®, which enhances the solubility, absorption and tolerability of established compounds - enabling improved, differentiated products across human and animal health.
Speaker
-
CEO · Avecho Biotechnology
Speaker